ADVM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ADVM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-06-10), Adverum Biotechnologies's current share price is $7.50. Adverum Biotechnologies's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $52.52. Adverum Biotechnologies's Cyclically Adjusted PB Ratio for today is 0.14.
The historical rank and industry rank for Adverum Biotechnologies's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, Adverum Biotechnologies's highest Cyclically Adjusted PB Ratio was 0.40. The lowest was 0.13. And the median was 0.20.
ADVM's Cyclically Adjusted PB Ratio is ranked better thanThe Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Adverum Biotechnologies's adjusted book value per share data for the three months ended in Mar. 2024 was $8.783. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $52.52 for the trailing ten years ended in Mar. 2024.
The historical data trend for Adverum Biotechnologies's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adverum Biotechnologies Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | 0.14 | 0.30 | 0.29 | 0.14 | 0.27 |
For the Biotechnology subindustry, Adverum Biotechnologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Adverum Biotechnologies's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Adverum Biotechnologies's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Adverum Biotechnologies's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 7.50 | / | 52.52 | |
= | 0.14 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adverum Biotechnologies's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:
For example, Adverum Biotechnologies's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:
Adj_Book | = | Book Value per Share | / | CPI of Mar. 2024 (Change) | * | Current CPI (Mar. 2024) |
= | 8.783 | / | 131.7762 | * | 131.7762 | |
= | 8.783 |
Current CPI (Mar. 2024) = 131.7762.
Adverum Biotechnologies Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201406 | -7.945 | 100.560 | -10.411 |
201409 | 69.307 | 100.428 | 90.941 |
201412 | 65.695 | 99.070 | 87.383 |
201503 | 109.791 | 99.621 | 145.229 |
201506 | 105.404 | 100.684 | 137.954 |
201509 | 101.852 | 100.392 | 133.693 |
201512 | 97.682 | 99.792 | 128.989 |
201603 | 89.155 | 100.470 | 116.935 |
201606 | 59.932 | 101.688 | 77.665 |
201609 | 56.625 | 101.861 | 73.255 |
201612 | 51.573 | 101.863 | 66.718 |
201703 | 47.073 | 102.862 | 60.305 |
201706 | 44.484 | 103.349 | 56.720 |
201709 | 41.591 | 104.136 | 52.630 |
201712 | 37.545 | 104.011 | 47.567 |
201803 | 39.536 | 105.290 | 49.482 |
201806 | 37.270 | 106.317 | 46.195 |
201809 | 34.309 | 106.507 | 42.449 |
201812 | 31.949 | 105.998 | 39.719 |
201903 | 29.706 | 107.251 | 36.499 |
201906 | 27.609 | 108.070 | 33.665 |
201909 | 25.427 | 108.329 | 30.930 |
201912 | 25.985 | 108.420 | 31.583 |
202003 | 38.052 | 108.902 | 46.045 |
202006 | 35.040 | 108.767 | 42.452 |
202009 | 47.679 | 109.815 | 57.214 |
202012 | 44.526 | 109.897 | 53.391 |
202103 | 42.360 | 111.754 | 49.949 |
202106 | 38.641 | 114.631 | 44.420 |
202109 | 35.255 | 115.734 | 40.142 |
202112 | 32.139 | 117.630 | 36.004 |
202203 | 28.648 | 121.301 | 31.122 |
202206 | 24.591 | 125.017 | 25.921 |
202209 | 20.891 | 125.227 | 21.984 |
202212 | 18.131 | 125.222 | 19.080 |
202303 | 15.686 | 127.348 | 16.231 |
202306 | 12.987 | 128.729 | 13.294 |
202309 | 10.167 | 129.860 | 10.317 |
202312 | 8.229 | 129.419 | 8.379 |
202403 | 8.783 | 131.776 | 8.783 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of Adverum Biotechnologies's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
C. David Nicholson, | director | 103 CHILDS ROAD, BASKIN RIDGE NJ 07092 |
Setareh Seyedkazemi | officer: Chief Development Officer | C/O ADVERUM BIOTECHNOLOGIES, INC., 100 CARDINAL DRIVE, REDWOOD CITY CA 94063 |
Linda M Rubinstein | officer: Chief Financial Officer | 25861 INDUSTRIAL BLVD, HAYWARD CA 94545 |
Peter Soparkar | officer: Chief Legal Officer | C/O ADVERUM BIOTECHNOLOGIES, INC., 100 CARDINAL WAY, REDWOOD CITY CA 94063 |
Brigit Riley | officer: Chief Scientific Officer | 100 CARDINAL WAY, REDWOOD CITY CA 94063 |
Laurent Fischer | director, officer: CEO and Director | C/O ADVERUM BIOTECHNOLOGIES, INC., 100 CARDINAL WAY, REDWOOD CITY CA 94063 |
Richard Beckman | officer: Chief Medical Officer | C/O ADVERUM BIOTECHNOLOGIES, INC., 100 CARDINAL WAY, REDWOOD CITY CA 94063 |
Nancy E Pecota | officer: Principal Accounting Officer | ARADIGM CORPORATION, 3929 POINT EDEN WAY, HAYWARD CA 94545 |
John Rakow | officer: SVP, Genl Counsel, Acting CFO | C/O ADVERUM BIOTECHNOLOGIES, INC., 100 CARDINAL WAY, REDWOOD CITY CA 94063 |
Rupert D'souza | officer: Chief Financial Officer | C/O ADVERUM BIOTECHNOLOGIES, INC., 100 CARDINAL WAY, REDWOOD CITY CA 94063 |
Dawn Svoronos | director | C/O MEDIVATION, INC., 525 MARKET ST., 36TH FLOOR, SAN FRANCISCO CA 94105 |
Soo Hong | director | C/O ADVERUM BIOTECHNOLOGIES, INC., 800 SAGINAW DRIVE, REDWOOD CITY CA 94063 |
Rabia Gurses Ozden | director | C/O AKOUOS, INC., 645 SUMMER STREET SUITE 200, BOSTON MA 02210 |
James Paul Scopa | director | 601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO CA 94080 |
Julie Clark | officer: Chief Medical Officer | C/O ADVERUM BIOTECHNOLOGIES, INC., 800 SAGINAW DRIVE, REDWOOD CITY CA 94063 |
From GuruFocus
By PurpleRose PurpleRose • 08-26-2022
By Marketwired • 09-21-2023
By sperokesalga sperokesalga • 04-17-2023
By Marketwired • 11-06-2023
By Marketwired • 08-10-2023
By sperokesalga sperokesalga • 04-18-2023
By Value_Insider Value_Insider • 11-04-2022
By GlobeNewswire • 11-04-2023
By sperokesalga sperokesalga • 06-12-2023
By Marketwired • 09-05-2023